Current Ratio in % of Apellis Pharmaceuticals, Inc. from Q2 2018 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Apellis Pharmaceuticals, Inc. quarterly Current Ratio history and change rate from Q2 2018 to Q3 2025.
Apellis Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 387 %, a 2.72% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	387	-10.8	-2.72%	30 Sep 2025
Q2 2025	411	+15.4	+3.9%	30 Jun 2025
Q1 2025	443	+46.4	+11.7%	31 Mar 2025
Q4 2024	433	-23.9	-5.24%	31 Dec 2024
Q3 2024	397	-107	-21.2%	30 Sep 2024
Q2 2024	396	-174	-30.6%	30 Jun 2024
Q1 2024	397	-235	-37.2%	31 Mar 2024
Q4 2023	457	-220	-32.5%	31 Dec 2023
Q3 2023	504	-241	-32.4%	30 Sep 2023
Q2 2023	570	-134	-19.1%	30 Jun 2023
Q1 2023	632	+30.5	+5.08%	31 Mar 2023
Q4 2022	676	+92.7	+15.9%	31 Dec 2022
Q3 2022	746	+138	+22.6%	30 Sep 2022
Q2 2022	704	+10.3	+1.48%	30 Jun 2022
Q1 2022	601	-351	-36.8%	31 Mar 2022
Q4 2021	584	-436	-42.8%	31 Dec 2021
Q3 2021	608	-450	-42.5%	30 Sep 2021
Q2 2021	694	-379	-35.3%	30 Jun 2021
Q1 2021	952	+34.1	+3.72%	31 Mar 2021
Q4 2020	1.02K	+152	+17.5%	31 Dec 2020
Q3 2020	1.06K	-24.7	-2.28%	30 Sep 2020
Q2 2020	1.07K	-118	-9.9%	30 Jun 2020
Q1 2020	918	-681	-42.6%	31 Mar 2020
Q4 2019	868	-854	-49.6%	31 Dec 2019
Q3 2019	1.08K	-1.04K	-48.9%	30 Sep 2019
Q2 2019	1.19K	-841	-41.4%	30 Jun 2019
Q1 2019	1.6K			31 Mar 2019
Q4 2018	1.72K			31 Dec 2018
Q3 2018	2.12K			30 Sep 2018
Q2 2018	2.03K			30 Jun 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.